⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1527318 | 1.00 | — | — | |
| SCHEMBL198216 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL334532 | 0.97 | SLC7A5 (0.46) | — | |
| Trifluoroacetic Acid SCHEMBL28707200 | 0.87 | GRB2 (0.41) | — | |
| SCHEMBL21417572 | 0.79 | — | — | |
| SCHEMBL21700150 | 0.79 | — | — | |
| SCHEMBL29951404 | 0.78 | SLC1A2 (0.43) | — | |
| SCHEMBL9616110 | 0.77 | DPP4 (0.32) | — | |
| SCHEMBL25357511 | 0.77 | BHMT (0.54) | — | |
| SCHEMBL25357506 | 0.77 | BHMT (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 588 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2025-07-08 | — | — | US | claimed |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2023-04-13 | — | — | US | claimed |
| US-20220372022-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2022-11-24 | — | — | US | claimed |
| CN-113769108-A | Conjugates of cysteine engineered antibodies | 伊缪诺金公司 | 2021-12-10 | — | — | CN | claimed |
| US-20210032304-A1 | FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2021-02-04 | — | — | US | claimed |
| EP-3752174-A1 | FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF | University of Florida Research Foundation, Incorporated (US) | 2020-12-23 | — | — | EP | claimed |
| CN-111936157-A | Fibroblast growth factor analogs and uses thereof | 佛罗里达大学研究基金会 | 2020-11-13 | — | — | CN | claimed |
| WO-2019160910-A1 | FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2019-08-22 | — | — | WO | claimed |
| EP-3313845-A1 | CONJUGATES OF CYSTEINE ENGINEERED ANTIBODIES | ImmunoGen, Inc. (US) | 2018-05-02 | — | — | EP | claimed |
| EP-1449917-B1 | PROCESS FOR PRODUCING L-AMINO ACID USING ESCHERICHIA | AJINOMOTO KK (JP) | 2006-07-26 | — | — | EP | claimed |
| EP-1017358-B1 | REDUCTION OF HAIR GROWTH | GILLETTE CO (US) | 2004-08-11 | — | — | EP | claimed |
| EP-1017358-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2000-07-12 | — | — | EP | claimed |
| EP-0979827-A1 | Peptides having tachykinin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | Boehringer Ingelheim Pharma KG (DE) | 2000-02-16 | — | — | EP | claimed |
| US-5939458-A | APPLYING AN INHIBITOR OF AMINOACYL-TRNA SYNTHETASE TO THE SKIN | GILLETTE COMPANY, THE | 1999-08-17 | — | — | US | claimed |
| WO-1999015136-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 1999-04-01 | — | — | WO | claimed |
| EP-0804463-A1 | NEUROKININE (TACHYKININE) ANTAGONISTS | BOEHRINGER INGELHEIM KG (DE) | 1997-11-05 | — | — | EP | claimed |
| WO-1995030687-A1 | NEUROKININE (TACHYKININE) ANTAGONISTS | BOEHRINGER INGELHEIM KG (DE) | 1995-11-16 | — | — | WO | claimed |
| EP-0610487-A1 | NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1994-08-17 | — | — | EP | claimed |
| WO-1994005693-A1 | NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1994-03-17 | — | — | WO | claimed |